Cargando…

Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study

BACKGROUND: Vascular abnormalities and endothelial dysfunction are part of the spectrum of autosomal dominant polycystic kidney disease (ADPKD). The mechanisms behind these manifestations, including potential effects on the endothelial surface layer (ESL) and glycocalyx integrity, remain unknown. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuchs, Alexander, Dederichs, Jennifer, Arjune, Sita, Todorova, Polina, Wöstmann, Fabian, Antczak, Philipp, Illerhaus, Anja, Gathof, Birgit, Grundmann, Franziska, Müller, Roman-Ulrich, Annecke, Thorsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900573/
https://www.ncbi.nlm.nih.gov/pubmed/36755834
http://dx.doi.org/10.1093/ckj/sfac229
_version_ 1784882877146595328
author Fuchs, Alexander
Dederichs, Jennifer
Arjune, Sita
Todorova, Polina
Wöstmann, Fabian
Antczak, Philipp
Illerhaus, Anja
Gathof, Birgit
Grundmann, Franziska
Müller, Roman-Ulrich
Annecke, Thorsten
author_facet Fuchs, Alexander
Dederichs, Jennifer
Arjune, Sita
Todorova, Polina
Wöstmann, Fabian
Antczak, Philipp
Illerhaus, Anja
Gathof, Birgit
Grundmann, Franziska
Müller, Roman-Ulrich
Annecke, Thorsten
author_sort Fuchs, Alexander
collection PubMed
description BACKGROUND: Vascular abnormalities and endothelial dysfunction are part of the spectrum of autosomal dominant polycystic kidney disease (ADPKD). The mechanisms behind these manifestations, including potential effects on the endothelial surface layer (ESL) and glycocalyx integrity, remain unknown. METHODS: Forty-five ambulatory adult patients with ADPKD were enrolled in this prospective, observational, cross-sectional, single-centre study. Fifty-one healthy volunteers served as a control group. All participants underwent real-time microvascular perfusion measurements of the sublingual microcirculation using sidestream dark field imaging. After image acquisition, the perfused boundary region (PBR), an inverse parameter for red blood cell (RBC) penetration into the ESL, was automatically calculated. Microvascular perfusion was assessed by RBC filling and capillary density. Concentrations of circulating glycocalyx components were determined by enzyme-linked immunosorbent assay. RESULTS: ADPKD patients showed a significantly larger PBR compared with healthy controls (2.09 ± 0.23 µm versus 1.79 ± 0.25 µm; P < .001). This was accompanied by significantly lower RBC filling (70.4 ± 5.0% versus 77.9 ± 5.4%; P < .001) as well as a higher valid capillary density {318/mm(2) [interquartile range (IQR) 269–380] versus 273/mm(2) [230–327]; P = .007}. Significantly higher plasma concentrations of heparan sulphate (1625 ± 807 ng/ml versus 1329 ± 316 ng/ml; P = .034), hyaluronan (111 ng/ml [IQR 79–132] versus 92 ng/ml [82–98]; P = .042) and syndecan-1 were noted in ADPKD patients compared with healthy controls (35 ng/ml [IQR 27–57] versus 29 ng/ml [23–42]; P = .035). CONCLUSIONS: Dimensions and integrity of the ESL are impaired in ADPKD patients. Increased capillary density may be a compensatory mechanism for vascular dysfunction to ensure sufficient tissue perfusion and oxygenation.
format Online
Article
Text
id pubmed-9900573
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-99005732023-02-07 Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study Fuchs, Alexander Dederichs, Jennifer Arjune, Sita Todorova, Polina Wöstmann, Fabian Antczak, Philipp Illerhaus, Anja Gathof, Birgit Grundmann, Franziska Müller, Roman-Ulrich Annecke, Thorsten Clin Kidney J Original Article BACKGROUND: Vascular abnormalities and endothelial dysfunction are part of the spectrum of autosomal dominant polycystic kidney disease (ADPKD). The mechanisms behind these manifestations, including potential effects on the endothelial surface layer (ESL) and glycocalyx integrity, remain unknown. METHODS: Forty-five ambulatory adult patients with ADPKD were enrolled in this prospective, observational, cross-sectional, single-centre study. Fifty-one healthy volunteers served as a control group. All participants underwent real-time microvascular perfusion measurements of the sublingual microcirculation using sidestream dark field imaging. After image acquisition, the perfused boundary region (PBR), an inverse parameter for red blood cell (RBC) penetration into the ESL, was automatically calculated. Microvascular perfusion was assessed by RBC filling and capillary density. Concentrations of circulating glycocalyx components were determined by enzyme-linked immunosorbent assay. RESULTS: ADPKD patients showed a significantly larger PBR compared with healthy controls (2.09 ± 0.23 µm versus 1.79 ± 0.25 µm; P < .001). This was accompanied by significantly lower RBC filling (70.4 ± 5.0% versus 77.9 ± 5.4%; P < .001) as well as a higher valid capillary density {318/mm(2) [interquartile range (IQR) 269–380] versus 273/mm(2) [230–327]; P = .007}. Significantly higher plasma concentrations of heparan sulphate (1625 ± 807 ng/ml versus 1329 ± 316 ng/ml; P = .034), hyaluronan (111 ng/ml [IQR 79–132] versus 92 ng/ml [82–98]; P = .042) and syndecan-1 were noted in ADPKD patients compared with healthy controls (35 ng/ml [IQR 27–57] versus 29 ng/ml [23–42]; P = .035). CONCLUSIONS: Dimensions and integrity of the ESL are impaired in ADPKD patients. Increased capillary density may be a compensatory mechanism for vascular dysfunction to ensure sufficient tissue perfusion and oxygenation. Oxford University Press 2022-10-19 /pmc/articles/PMC9900573/ /pubmed/36755834 http://dx.doi.org/10.1093/ckj/sfac229 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the ERA. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Article
Fuchs, Alexander
Dederichs, Jennifer
Arjune, Sita
Todorova, Polina
Wöstmann, Fabian
Antczak, Philipp
Illerhaus, Anja
Gathof, Birgit
Grundmann, Franziska
Müller, Roman-Ulrich
Annecke, Thorsten
Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study
title Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study
title_full Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study
title_fullStr Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study
title_full_unstemmed Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study
title_short Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study
title_sort microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the glycoscore iii study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900573/
https://www.ncbi.nlm.nih.gov/pubmed/36755834
http://dx.doi.org/10.1093/ckj/sfac229
work_keys_str_mv AT fuchsalexander microvascularperfusionperfusedboundaryregionandglycocalyxsheddinginpatientswithautosomaldominantpolycystickidneydiseaseresultsfromtheglycoscoreiiistudy
AT dederichsjennifer microvascularperfusionperfusedboundaryregionandglycocalyxsheddinginpatientswithautosomaldominantpolycystickidneydiseaseresultsfromtheglycoscoreiiistudy
AT arjunesita microvascularperfusionperfusedboundaryregionandglycocalyxsheddinginpatientswithautosomaldominantpolycystickidneydiseaseresultsfromtheglycoscoreiiistudy
AT todorovapolina microvascularperfusionperfusedboundaryregionandglycocalyxsheddinginpatientswithautosomaldominantpolycystickidneydiseaseresultsfromtheglycoscoreiiistudy
AT wostmannfabian microvascularperfusionperfusedboundaryregionandglycocalyxsheddinginpatientswithautosomaldominantpolycystickidneydiseaseresultsfromtheglycoscoreiiistudy
AT antczakphilipp microvascularperfusionperfusedboundaryregionandglycocalyxsheddinginpatientswithautosomaldominantpolycystickidneydiseaseresultsfromtheglycoscoreiiistudy
AT illerhausanja microvascularperfusionperfusedboundaryregionandglycocalyxsheddinginpatientswithautosomaldominantpolycystickidneydiseaseresultsfromtheglycoscoreiiistudy
AT gathofbirgit microvascularperfusionperfusedboundaryregionandglycocalyxsheddinginpatientswithautosomaldominantpolycystickidneydiseaseresultsfromtheglycoscoreiiistudy
AT grundmannfranziska microvascularperfusionperfusedboundaryregionandglycocalyxsheddinginpatientswithautosomaldominantpolycystickidneydiseaseresultsfromtheglycoscoreiiistudy
AT mullerromanulrich microvascularperfusionperfusedboundaryregionandglycocalyxsheddinginpatientswithautosomaldominantpolycystickidneydiseaseresultsfromtheglycoscoreiiistudy
AT anneckethorsten microvascularperfusionperfusedboundaryregionandglycocalyxsheddinginpatientswithautosomaldominantpolycystickidneydiseaseresultsfromtheglycoscoreiiistudy